By physician referral or invitation only

Tzield Registry for Stage 2 Type 1 Diabetes

The purpose of this study is to identify the long-term safety of TZIELD in Stage 2 T1D patients treated with TZIELD under real-world conditions. A comparison group of patients with Stage 2 T1D who were not treated with TZIELD will also be enrolled.

Age & Gender

8 years ~ 99 years
Male, Female, Gender Inclusive

Contact the Team

Location

Thank you for your interest, but this study is recruiting by invitation only.

United States (Nationwide)

Additional Study Information

Principal Investigator

Nina Jain
Pediatrics - Endocrinology

Study Type

Clinical or Medical
Observational

Study Topics

Diabetes

IRB Number

24-1359

ClinicalTrials.gov

NCT06481904

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Helpful Links

Questions?

This email address is being protected from spambots. You need JavaScript enabled to view it.